SlideShare a Scribd company logo
Apps to Transform Health and Care – That’s
                 HANDI

           www.handihealth.org




         HANDIHealth Community Interest Company
Why HANDI?



    Because we believe apps and the app
    paradigm can transform health and care
Dr Neill Jones

    General Practitioner

    Clinical Informatician

    Ex Clinical Director FDBE
    −   took product through the MDD
Medical device directive and the implications for
                Medical APPS

 
     Outline of the Presentation
 
     Medical Device Directive
 
     Clinical Safety
 
     Quality management systems
 
     What is a medical device
 
     What you need to do
 
     Definitions and concepts
Medical Devices Directive 93/42/EEC

    Requires manufacturers placing medical
    device(s) on the Community market

    Provide certain information to a Competent
    Authority in a Member State where they
    have a registered place of business.
Medical Device:
   any instrument, apparatus, appliance,
 software, material or other article, whether
used alone or in combination, including the
software intended by its manufacturer to be
   used specifically for diagnostic and/or
therapeutic purposes and necessary for its
     proper application, intended by the
manufacturer to be used for human beings
             for the purpose of:
Purpose of:

    diagnosis, prevention, monitoring,
    treatment or alleviation of disease,

    diagnosis, monitoring, treatment,
    alleviation of or compensation for an injury
    or handicap,

    investigation, replacement or modification
    of the anatomy or of a physiological
    process,
control of conception
which does not achieve its principal intended
 action in or on the human body by
 pharmacological, immunological or
 metabolic means, but which may be
 assisted in its function by such means;


Dose the POPE know he should register the
 rythm method as a medical device
DSCN 14/2009



   Application of Patient Safety Risk
Management to the Manufacture of Health
                Software
ISB 0129

    Health Informatics — Application of clinical
    risk management to the manufacture of
    health software
     (formerly ISO/TS 29321:2008(E))

    DSCN14/2009

    DSCN18/2009
Safety Risk analysis

    If the manufacturer can provide information
    showing that a safe design has been
    established for a number of years and that
    the product has been performing as
    intended during that time such information
    is likely to be sufficient to cover this
    requirement
Modules
Some stand alone software may break down
 into a significant number of applications for
 the user where each of these applications
 is correlated with a module.

Some of these modules may have a medical
 purpose.
This raises the issue as to whether the whole product can be CE marked when not all applications have a medical purpose
It is the obligation of the manufacturer to identify the boundaries and the interfaces of the different modules/applications.
SOS intended for use in combination with other modules of the whole software structure, other devices or equipment, the whole
    combination, including the connection system, must be safe and must not impair the specified performances of the modules
    which are subject to the medical device Directives.
POST MARKET SURVEILLANCE

    The Directive seeks to improve the protection of health and
    safety of patients, by reducing the likelihood of similar
    incidents being repeated. Consequently, the Regulations
    require the manufacturer to immediately notify the Competent
    Authority if the product has been involved in an incident:

    Led to a death;

    A serious injury or serious deterioration in the state of health

    That might have led to death, serious injury
DECLARATION OF CONFORMITY
EC DECLARATION OF CONFORMITY
 (Full quality assurance system)
The manufacturer must ensure application of
 the quality system approved for the design,
 manufacture and final inspection of the
 products concerned, as specified in Section
 3 and is subject to audit as laid down in
 Sections 3.3 and 4 and to Community
 surveillance as specified in Section 5.
What is a medical device

    Any complex algorithm upon which a
    clinician may rely on where the calculation
    is not apparent to the clinician.

    The software used for the Pandemic flu
    line has been classified as a medical
    device because it lead to patients receiving
    (or not) a medication.

    CVS risk scope is almost certainly the
    same category.
Decision Support Software
Computer based tools which combines
 medical knowledge databases and
 algorithms with patient specific data.
They are intended to provide healthcare
 professionals and/or users with
 recommendations for or information on
 diagnosis, prognosis, monitoring and
 treatment of individual patients.
Active device for diagnosis:
Any active medical device, whether used
 alone or in combination with other medical
 devices, to supply information for detecting,
 diagnosing, monitoring or treating
 physiological conditions, states of health,
 illnesses or congenital deformities.
Drug dosing systems
To calculate the drug dosage to be
  administered to a specific patient and
  therefore are qualified as medical devices.
This would include drug doses filter by age
 sex gender indication.
Expert function software:
software which is able to analyse existing
  information to generate new specific
  information according to the intended use
  of the software.
Intended purpose:
the use for which the device is intended
  according to the data supplied by the
  manufacturer on the labelling, in the
  instructions and/or in promotional materials.
Placing on the market:
the first making available in return for
  payment or free of charge of a device
  other than a device intended for clinical
  investigation, with a view to distribution
  and/or use on the Community market,
  regardless of whether it is new or fully
  refurbished.
Summary

    If an APP influences a Clinician and
    probably also a Patient that results in
    subsequent therapy you should seriously
    consider if it is covered by the MDD and
    seek expert guidance

    Clinical safety and quality management
    systems together with post marketing
    survelance are critical to the process.
Questions

    Neill.jones@nhs.net

    MDD At MHRA

    Full Directive
www.handihealth.org
                   info@handihealth.org




Handi Health Community Interest Company - limited by guarantee registered in England number 07999302
Registered Office: The Oakley, Kidderminster Rd, Droitwich, Worcestershire. WR9 9AY
Correspondence address: PO Box 5309 Leamington Spa, CV31 9GT

More Related Content

What's hot

Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
TGA Australia
 
mHealth Israel_Digital Health_The Regulatory Landscape 2017
mHealth Israel_Digital Health_The Regulatory Landscape 2017mHealth Israel_Digital Health_The Regulatory Landscape 2017
mHealth Israel_Digital Health_The Regulatory Landscape 2017
Levi Shapiro
 
Regulation of software as medical devices
Regulation of software as medical devicesRegulation of software as medical devices
Regulation of software as medical devices
TGA Australia
 
European Clinical Trial Safety Focus
European  Clinical Trial Safety FocusEuropean  Clinical Trial Safety Focus
European Clinical Trial Safety Focus
Vaska Toné
 
Update on software as a medical device (SaMD)
Update on software as a medical device (SaMD)Update on software as a medical device (SaMD)
Update on software as a medical device (SaMD)
TGA Australia
 
Medwatch and FAERS database
Medwatch and FAERS databaseMedwatch and FAERS database
Medwatch and FAERS database
Dr. Ashish singh parihar
 
Presentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access BranchPresentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access Branch
TGA Australia
 
Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...
TGA Australia
 
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA Australia
 
EU Medical Device Regulation: Preparing for Disruptive (yet Incomplete) Regu...
EU Medical Device Regulation:  Preparing for Disruptive (yet Incomplete) Regu...EU Medical Device Regulation:  Preparing for Disruptive (yet Incomplete) Regu...
EU Medical Device Regulation: Preparing for Disruptive (yet Incomplete) Regu...
YourEncoreInc
 
Cliniminds- Skill Development Program in Pharmacovigilance
Cliniminds- Skill Development Program in PharmacovigilanceCliniminds- Skill Development Program in Pharmacovigilance
Cliniminds- Skill Development Program in Pharmacovigilance
Cliniminds India
 
Pharmacovigilance
Pharmacovigilance Pharmacovigilance
Pharmacovigilance
Wallace Macindoe PhD MBA
 
The regulation of software: Medicines, biologicals, blood, tissues and devices
The regulation of software: Medicines, biologicals, blood, tissues and devicesThe regulation of software: Medicines, biologicals, blood, tissues and devices
The regulation of software: Medicines, biologicals, blood, tissues and devices
TGA Australia
 
Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
Presentation: Therapeutic Goods Advertising Code (No. 2) 2018Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Australia
 
Materiovigilance programme of india by akhilesh sachan
Materiovigilance programme of india by akhilesh sachanMateriovigilance programme of india by akhilesh sachan
Materiovigilance programme of india by akhilesh sachan
Akhilesh Sachan
 
Postmarket Surveillance Medical Devices
Postmarket Surveillance   Medical DevicesPostmarket Surveillance   Medical Devices
Postmarket Surveillance Medical Devices
Jacobe2008
 
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Australia
 
Tools Available to the FDA to Assess Patient Safety
Tools Available to the FDA to Assess Patient SafetyTools Available to the FDA to Assess Patient Safety
Tools Available to the FDA to Assess Patient Safety
EMMAIntl
 
A Survey on Current Applications for Tracking COVID-19
A Survey on Current Applications for Tracking COVID-19A Survey on Current Applications for Tracking COVID-19
A Survey on Current Applications for Tracking COVID-19
EMMAIntl
 
Presentation: Medical Devices: how to stay included workshop - Adverse event ...
Presentation: Medical Devices: how to stay included workshop - Adverse event ...Presentation: Medical Devices: how to stay included workshop - Adverse event ...
Presentation: Medical Devices: how to stay included workshop - Adverse event ...
TGA Australia
 

What's hot (20)

Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
 
mHealth Israel_Digital Health_The Regulatory Landscape 2017
mHealth Israel_Digital Health_The Regulatory Landscape 2017mHealth Israel_Digital Health_The Regulatory Landscape 2017
mHealth Israel_Digital Health_The Regulatory Landscape 2017
 
Regulation of software as medical devices
Regulation of software as medical devicesRegulation of software as medical devices
Regulation of software as medical devices
 
European Clinical Trial Safety Focus
European  Clinical Trial Safety FocusEuropean  Clinical Trial Safety Focus
European Clinical Trial Safety Focus
 
Update on software as a medical device (SaMD)
Update on software as a medical device (SaMD)Update on software as a medical device (SaMD)
Update on software as a medical device (SaMD)
 
Medwatch and FAERS database
Medwatch and FAERS databaseMedwatch and FAERS database
Medwatch and FAERS database
 
Presentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access BranchPresentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access Branch
 
Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...
 
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
 
EU Medical Device Regulation: Preparing for Disruptive (yet Incomplete) Regu...
EU Medical Device Regulation:  Preparing for Disruptive (yet Incomplete) Regu...EU Medical Device Regulation:  Preparing for Disruptive (yet Incomplete) Regu...
EU Medical Device Regulation: Preparing for Disruptive (yet Incomplete) Regu...
 
Cliniminds- Skill Development Program in Pharmacovigilance
Cliniminds- Skill Development Program in PharmacovigilanceCliniminds- Skill Development Program in Pharmacovigilance
Cliniminds- Skill Development Program in Pharmacovigilance
 
Pharmacovigilance
Pharmacovigilance Pharmacovigilance
Pharmacovigilance
 
The regulation of software: Medicines, biologicals, blood, tissues and devices
The regulation of software: Medicines, biologicals, blood, tissues and devicesThe regulation of software: Medicines, biologicals, blood, tissues and devices
The regulation of software: Medicines, biologicals, blood, tissues and devices
 
Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
Presentation: Therapeutic Goods Advertising Code (No. 2) 2018Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
 
Materiovigilance programme of india by akhilesh sachan
Materiovigilance programme of india by akhilesh sachanMateriovigilance programme of india by akhilesh sachan
Materiovigilance programme of india by akhilesh sachan
 
Postmarket Surveillance Medical Devices
Postmarket Surveillance   Medical DevicesPostmarket Surveillance   Medical Devices
Postmarket Surveillance Medical Devices
 
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
 
Tools Available to the FDA to Assess Patient Safety
Tools Available to the FDA to Assess Patient SafetyTools Available to the FDA to Assess Patient Safety
Tools Available to the FDA to Assess Patient Safety
 
A Survey on Current Applications for Tracking COVID-19
A Survey on Current Applications for Tracking COVID-19A Survey on Current Applications for Tracking COVID-19
A Survey on Current Applications for Tracking COVID-19
 
Presentation: Medical Devices: how to stay included workshop - Adverse event ...
Presentation: Medical Devices: how to stay included workshop - Adverse event ...Presentation: Medical Devices: how to stay included workshop - Adverse event ...
Presentation: Medical Devices: how to stay included workshop - Adverse event ...
 

Similar to EU Medical Device Directive Newcastle May

Post Marketing Surveillance - RSI
Post Marketing Surveillance - RSIPost Marketing Surveillance - RSI
Post Marketing Surveillance - RSI
Regulatory Solutions India
 
Risk managements documents required for the market placement of a medical dev...
Risk managements documents required for the market placement of a medical dev...Risk managements documents required for the market placement of a medical dev...
Risk managements documents required for the market placement of a medical dev...
PEPGRA Healthcare
 
Safety monitoring and reporting of adverse events of medical devices national...
Safety monitoring and reporting of adverse events of medical devices national...Safety monitoring and reporting of adverse events of medical devices national...
Safety monitoring and reporting of adverse events of medical devices national...
Vivek Nayak
 
Software As Device - Frank Maxwell
Software As Device - Frank MaxwellSoftware As Device - Frank Maxwell
Software As Device - Frank Maxwellhealthcareisi
 
2011 raps presentation subcontractors software social media fox rev 2
2011 raps presentation subcontractors software social media fox rev 22011 raps presentation subcontractors software social media fox rev 2
2011 raps presentation subcontractors software social media fox rev 2
Erik Vollebregt
 
Presentation: Therapeutic Goods Administration: An introduction to the work o...
Presentation: Therapeutic Goods Administration: An introduction to the work o...Presentation: Therapeutic Goods Administration: An introduction to the work o...
Presentation: Therapeutic Goods Administration: An introduction to the work o...
TGA Australia
 
Clinical evaluation report cer in a more stringent regulatory- Pepgra Healthcare
Clinical evaluation report cer in a more stringent regulatory- Pepgra HealthcareClinical evaluation report cer in a more stringent regulatory- Pepgra Healthcare
Clinical evaluation report cer in a more stringent regulatory- Pepgra Healthcare
PEPGRA Healthcare
 
Software design for_medical_devices_europe_conferent_19012011[1]
Software design for_medical_devices_europe_conferent_19012011[1]Software design for_medical_devices_europe_conferent_19012011[1]
Software design for_medical_devices_europe_conferent_19012011[1]
Erik Vollebregt
 
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICESREGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
Arunpandiyan59
 
The challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devicesThe challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devices
TGA Australia
 
Cybersecurity in Medical Devices
Cybersecurity in Medical DevicesCybersecurity in Medical Devices
Cybersecurity in Medical Devices
Sheersha Pramanik 🇮🇳
 
Celine Deswarte EU #MWC14 #mHealth
Celine Deswarte EU #MWC14 #mHealthCeline Deswarte EU #MWC14 #mHealth
Celine Deswarte EU #MWC14 #mHealth3GDR
 
Freyr UDI Services
Freyr UDI ServicesFreyr UDI Services
Freyr UDI Services
Yasser Mohammad
 
Materiovigilance and AEFI ppt
Materiovigilance and AEFI pptMateriovigilance and AEFI ppt
Materiovigilance and AEFI ppt
JuliaWilson68
 
Presentation_Medical device registartion Malaysia.pdf
Presentation_Medical device registartion Malaysia.pdfPresentation_Medical device registartion Malaysia.pdf
Presentation_Medical device registartion Malaysia.pdf
andrijanakankaras1
 
Fda postmarket surveillance-report-september-remediated
Fda postmarket surveillance-report-september-remediatedFda postmarket surveillance-report-september-remediated
Fda postmarket surveillance-report-september-remediatedgarridosk
 
Breakout Session: Cybersecurity in Medical Devices
Breakout Session: Cybersecurity in Medical DevicesBreakout Session: Cybersecurity in Medical Devices
Breakout Session: Cybersecurity in Medical Devices
Healthegy
 
3..Post marketing surveillance.pptx
3..Post marketing surveillance.pptx3..Post marketing surveillance.pptx
3..Post marketing surveillance.pptx
KrishnapriyaVH1
 
The Value of Integrated Care
The Value of Integrated CareThe Value of Integrated Care
The Value of Integrated Care
Andrea MANTOVANI
 

Similar to EU Medical Device Directive Newcastle May (20)

Post Marketing Surveillance - RSI
Post Marketing Surveillance - RSIPost Marketing Surveillance - RSI
Post Marketing Surveillance - RSI
 
Risk managements documents required for the market placement of a medical dev...
Risk managements documents required for the market placement of a medical dev...Risk managements documents required for the market placement of a medical dev...
Risk managements documents required for the market placement of a medical dev...
 
Safety monitoring and reporting of adverse events of medical devices national...
Safety monitoring and reporting of adverse events of medical devices national...Safety monitoring and reporting of adverse events of medical devices national...
Safety monitoring and reporting of adverse events of medical devices national...
 
Software As Device - Frank Maxwell
Software As Device - Frank MaxwellSoftware As Device - Frank Maxwell
Software As Device - Frank Maxwell
 
2011 raps presentation subcontractors software social media fox rev 2
2011 raps presentation subcontractors software social media fox rev 22011 raps presentation subcontractors software social media fox rev 2
2011 raps presentation subcontractors software social media fox rev 2
 
Presentation: Therapeutic Goods Administration: An introduction to the work o...
Presentation: Therapeutic Goods Administration: An introduction to the work o...Presentation: Therapeutic Goods Administration: An introduction to the work o...
Presentation: Therapeutic Goods Administration: An introduction to the work o...
 
Clinical evaluation report cer in a more stringent regulatory- Pepgra Healthcare
Clinical evaluation report cer in a more stringent regulatory- Pepgra HealthcareClinical evaluation report cer in a more stringent regulatory- Pepgra Healthcare
Clinical evaluation report cer in a more stringent regulatory- Pepgra Healthcare
 
Software design for_medical_devices_europe_conferent_19012011[1]
Software design for_medical_devices_europe_conferent_19012011[1]Software design for_medical_devices_europe_conferent_19012011[1]
Software design for_medical_devices_europe_conferent_19012011[1]
 
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICESREGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
 
The challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devicesThe challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devices
 
Cybersecurity in Medical Devices
Cybersecurity in Medical DevicesCybersecurity in Medical Devices
Cybersecurity in Medical Devices
 
Celine Deswarte EU #MWC14 #mHealth
Celine Deswarte EU #MWC14 #mHealthCeline Deswarte EU #MWC14 #mHealth
Celine Deswarte EU #MWC14 #mHealth
 
Freyr UDI Services
Freyr UDI ServicesFreyr UDI Services
Freyr UDI Services
 
Materiovigilance and AEFI ppt
Materiovigilance and AEFI pptMateriovigilance and AEFI ppt
Materiovigilance and AEFI ppt
 
Presentation_Medical device registartion Malaysia.pdf
Presentation_Medical device registartion Malaysia.pdfPresentation_Medical device registartion Malaysia.pdf
Presentation_Medical device registartion Malaysia.pdf
 
Fda postmarket surveillance-report-september-remediated
Fda postmarket surveillance-report-september-remediatedFda postmarket surveillance-report-september-remediated
Fda postmarket surveillance-report-september-remediated
 
160428_WP_Medical_UDI_EN.PDF
160428_WP_Medical_UDI_EN.PDF160428_WP_Medical_UDI_EN.PDF
160428_WP_Medical_UDI_EN.PDF
 
Breakout Session: Cybersecurity in Medical Devices
Breakout Session: Cybersecurity in Medical DevicesBreakout Session: Cybersecurity in Medical Devices
Breakout Session: Cybersecurity in Medical Devices
 
3..Post marketing surveillance.pptx
3..Post marketing surveillance.pptx3..Post marketing surveillance.pptx
3..Post marketing surveillance.pptx
 
The Value of Integrated Care
The Value of Integrated CareThe Value of Integrated Care
The Value of Integrated Care
 

More from HANDI HEALTH

NHS England share Code4Health Challenge
NHS England share Code4Health ChallengeNHS England share Code4Health Challenge
NHS England share Code4Health Challenge
HANDI HEALTH
 
HANDI Summit 18 - Introducing HANDI-HOPD - Ewan Davis
HANDI Summit 18 - Introducing HANDI-HOPD - Ewan DavisHANDI Summit 18 - Introducing HANDI-HOPD - Ewan Davis
HANDI Summit 18 - Introducing HANDI-HOPD - Ewan Davis
HANDI HEALTH
 
HANDI Summit 18 - Introducing HANDI-HOPD - Dr Ian McNicoll
HANDI Summit 18 - Introducing HANDI-HOPD - Dr Ian McNicollHANDI Summit 18 - Introducing HANDI-HOPD - Dr Ian McNicoll
HANDI Summit 18 - Introducing HANDI-HOPD - Dr Ian McNicoll
HANDI HEALTH
 
HANDI Arctic Conf 2014
HANDI Arctic Conf 2014HANDI Arctic Conf 2014
HANDI Arctic Conf 2014
HANDI HEALTH
 
HANDI at Healthcare Innovation Expo
HANDI at Healthcare Innovation ExpoHANDI at Healthcare Innovation Expo
HANDI at Healthcare Innovation Expo
HANDI HEALTH
 
Emily Ashurst - Diabetes App Challange
Emily Ashurst - Diabetes App ChallangeEmily Ashurst - Diabetes App Challange
Emily Ashurst - Diabetes App Challange
HANDI HEALTH
 
Ian Grimley - Roxburgh Milkins LLP
Ian Grimley - Roxburgh Milkins LLPIan Grimley - Roxburgh Milkins LLP
Ian Grimley - Roxburgh Milkins LLP
HANDI HEALTH
 
HANDI Health - Innovation?
HANDI Health - Innovation?HANDI Health - Innovation?
HANDI Health - Innovation?
HANDI HEALTH
 
Hello HANDI
Hello HANDIHello HANDI
Hello HANDI
HANDI HEALTH
 
Service design
Service designService design
Service design
HANDI HEALTH
 
Why is interoperability hard
Why is interoperability hardWhy is interoperability hard
Why is interoperability hard
HANDI HEALTH
 
Apps in the clinical domain
Apps in the clinical domainApps in the clinical domain
Apps in the clinical domain
HANDI HEALTH
 
Hello HANDI
Hello HANDIHello HANDI
Hello HANDI
HANDI HEALTH
 
Information governance considerations in developing healthcare applications
Information governance considerations in developing healthcare applicationsInformation governance considerations in developing healthcare applications
Information governance considerations in developing healthcare applications
HANDI HEALTH
 

More from HANDI HEALTH (14)

NHS England share Code4Health Challenge
NHS England share Code4Health ChallengeNHS England share Code4Health Challenge
NHS England share Code4Health Challenge
 
HANDI Summit 18 - Introducing HANDI-HOPD - Ewan Davis
HANDI Summit 18 - Introducing HANDI-HOPD - Ewan DavisHANDI Summit 18 - Introducing HANDI-HOPD - Ewan Davis
HANDI Summit 18 - Introducing HANDI-HOPD - Ewan Davis
 
HANDI Summit 18 - Introducing HANDI-HOPD - Dr Ian McNicoll
HANDI Summit 18 - Introducing HANDI-HOPD - Dr Ian McNicollHANDI Summit 18 - Introducing HANDI-HOPD - Dr Ian McNicoll
HANDI Summit 18 - Introducing HANDI-HOPD - Dr Ian McNicoll
 
HANDI Arctic Conf 2014
HANDI Arctic Conf 2014HANDI Arctic Conf 2014
HANDI Arctic Conf 2014
 
HANDI at Healthcare Innovation Expo
HANDI at Healthcare Innovation ExpoHANDI at Healthcare Innovation Expo
HANDI at Healthcare Innovation Expo
 
Emily Ashurst - Diabetes App Challange
Emily Ashurst - Diabetes App ChallangeEmily Ashurst - Diabetes App Challange
Emily Ashurst - Diabetes App Challange
 
Ian Grimley - Roxburgh Milkins LLP
Ian Grimley - Roxburgh Milkins LLPIan Grimley - Roxburgh Milkins LLP
Ian Grimley - Roxburgh Milkins LLP
 
HANDI Health - Innovation?
HANDI Health - Innovation?HANDI Health - Innovation?
HANDI Health - Innovation?
 
Hello HANDI
Hello HANDIHello HANDI
Hello HANDI
 
Service design
Service designService design
Service design
 
Why is interoperability hard
Why is interoperability hardWhy is interoperability hard
Why is interoperability hard
 
Apps in the clinical domain
Apps in the clinical domainApps in the clinical domain
Apps in the clinical domain
 
Hello HANDI
Hello HANDIHello HANDI
Hello HANDI
 
Information governance considerations in developing healthcare applications
Information governance considerations in developing healthcare applicationsInformation governance considerations in developing healthcare applications
Information governance considerations in developing healthcare applications
 

Recently uploaded

PHP Frameworks: I want to break free (IPC Berlin 2024)
PHP Frameworks: I want to break free (IPC Berlin 2024)PHP Frameworks: I want to break free (IPC Berlin 2024)
PHP Frameworks: I want to break free (IPC Berlin 2024)
Ralf Eggert
 
When stars align: studies in data quality, knowledge graphs, and machine lear...
When stars align: studies in data quality, knowledge graphs, and machine lear...When stars align: studies in data quality, knowledge graphs, and machine lear...
When stars align: studies in data quality, knowledge graphs, and machine lear...
Elena Simperl
 
Essentials of Automations: Optimizing FME Workflows with Parameters
Essentials of Automations: Optimizing FME Workflows with ParametersEssentials of Automations: Optimizing FME Workflows with Parameters
Essentials of Automations: Optimizing FME Workflows with Parameters
Safe Software
 
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Tobias Schneck
 
DevOps and Testing slides at DASA Connect
DevOps and Testing slides at DASA ConnectDevOps and Testing slides at DASA Connect
DevOps and Testing slides at DASA Connect
Kari Kakkonen
 
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
UiPathCommunity
 
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered QualitySoftware Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Inflectra
 
How world-class product teams are winning in the AI era by CEO and Founder, P...
How world-class product teams are winning in the AI era by CEO and Founder, P...How world-class product teams are winning in the AI era by CEO and Founder, P...
How world-class product teams are winning in the AI era by CEO and Founder, P...
Product School
 
Connector Corner: Automate dynamic content and events by pushing a button
Connector Corner: Automate dynamic content and events by pushing a buttonConnector Corner: Automate dynamic content and events by pushing a button
Connector Corner: Automate dynamic content and events by pushing a button
DianaGray10
 
Knowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and backKnowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and back
Elena Simperl
 
Builder.ai Founder Sachin Dev Duggal's Strategic Approach to Create an Innova...
Builder.ai Founder Sachin Dev Duggal's Strategic Approach to Create an Innova...Builder.ai Founder Sachin Dev Duggal's Strategic Approach to Create an Innova...
Builder.ai Founder Sachin Dev Duggal's Strategic Approach to Create an Innova...
Ramesh Iyer
 
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
BookNet Canada
 
Mission to Decommission: Importance of Decommissioning Products to Increase E...
Mission to Decommission: Importance of Decommissioning Products to Increase E...Mission to Decommission: Importance of Decommissioning Products to Increase E...
Mission to Decommission: Importance of Decommissioning Products to Increase E...
Product School
 
Assuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyesAssuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyes
ThousandEyes
 
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Product School
 
GraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge GraphGraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge Graph
Guy Korland
 
ODC, Data Fabric and Architecture User Group
ODC, Data Fabric and Architecture User GroupODC, Data Fabric and Architecture User Group
ODC, Data Fabric and Architecture User Group
CatarinaPereira64715
 
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
Product School
 
"Impact of front-end architecture on development cost", Viktor Turskyi
"Impact of front-end architecture on development cost", Viktor Turskyi"Impact of front-end architecture on development cost", Viktor Turskyi
"Impact of front-end architecture on development cost", Viktor Turskyi
Fwdays
 
Bits & Pixels using AI for Good.........
Bits & Pixels using AI for Good.........Bits & Pixels using AI for Good.........
Bits & Pixels using AI for Good.........
Alison B. Lowndes
 

Recently uploaded (20)

PHP Frameworks: I want to break free (IPC Berlin 2024)
PHP Frameworks: I want to break free (IPC Berlin 2024)PHP Frameworks: I want to break free (IPC Berlin 2024)
PHP Frameworks: I want to break free (IPC Berlin 2024)
 
When stars align: studies in data quality, knowledge graphs, and machine lear...
When stars align: studies in data quality, knowledge graphs, and machine lear...When stars align: studies in data quality, knowledge graphs, and machine lear...
When stars align: studies in data quality, knowledge graphs, and machine lear...
 
Essentials of Automations: Optimizing FME Workflows with Parameters
Essentials of Automations: Optimizing FME Workflows with ParametersEssentials of Automations: Optimizing FME Workflows with Parameters
Essentials of Automations: Optimizing FME Workflows with Parameters
 
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
 
DevOps and Testing slides at DASA Connect
DevOps and Testing slides at DASA ConnectDevOps and Testing slides at DASA Connect
DevOps and Testing slides at DASA Connect
 
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
 
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered QualitySoftware Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
 
How world-class product teams are winning in the AI era by CEO and Founder, P...
How world-class product teams are winning in the AI era by CEO and Founder, P...How world-class product teams are winning in the AI era by CEO and Founder, P...
How world-class product teams are winning in the AI era by CEO and Founder, P...
 
Connector Corner: Automate dynamic content and events by pushing a button
Connector Corner: Automate dynamic content and events by pushing a buttonConnector Corner: Automate dynamic content and events by pushing a button
Connector Corner: Automate dynamic content and events by pushing a button
 
Knowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and backKnowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and back
 
Builder.ai Founder Sachin Dev Duggal's Strategic Approach to Create an Innova...
Builder.ai Founder Sachin Dev Duggal's Strategic Approach to Create an Innova...Builder.ai Founder Sachin Dev Duggal's Strategic Approach to Create an Innova...
Builder.ai Founder Sachin Dev Duggal's Strategic Approach to Create an Innova...
 
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
 
Mission to Decommission: Importance of Decommissioning Products to Increase E...
Mission to Decommission: Importance of Decommissioning Products to Increase E...Mission to Decommission: Importance of Decommissioning Products to Increase E...
Mission to Decommission: Importance of Decommissioning Products to Increase E...
 
Assuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyesAssuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyes
 
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
 
GraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge GraphGraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge Graph
 
ODC, Data Fabric and Architecture User Group
ODC, Data Fabric and Architecture User GroupODC, Data Fabric and Architecture User Group
ODC, Data Fabric and Architecture User Group
 
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
 
"Impact of front-end architecture on development cost", Viktor Turskyi
"Impact of front-end architecture on development cost", Viktor Turskyi"Impact of front-end architecture on development cost", Viktor Turskyi
"Impact of front-end architecture on development cost", Viktor Turskyi
 
Bits & Pixels using AI for Good.........
Bits & Pixels using AI for Good.........Bits & Pixels using AI for Good.........
Bits & Pixels using AI for Good.........
 

EU Medical Device Directive Newcastle May

  • 1. Apps to Transform Health and Care – That’s HANDI www.handihealth.org HANDIHealth Community Interest Company
  • 2. Why HANDI?  Because we believe apps and the app paradigm can transform health and care
  • 3. Dr Neill Jones  General Practitioner  Clinical Informatician  Ex Clinical Director FDBE − took product through the MDD
  • 4. Medical device directive and the implications for Medical APPS  Outline of the Presentation  Medical Device Directive  Clinical Safety  Quality management systems  What is a medical device  What you need to do  Definitions and concepts
  • 5. Medical Devices Directive 93/42/EEC  Requires manufacturers placing medical device(s) on the Community market  Provide certain information to a Competent Authority in a Member State where they have a registered place of business.
  • 6. Medical Device: any instrument, apparatus, appliance, software, material or other article, whether used alone or in combination, including the software intended by its manufacturer to be used specifically for diagnostic and/or therapeutic purposes and necessary for its proper application, intended by the manufacturer to be used for human beings for the purpose of:
  • 7. Purpose of:  diagnosis, prevention, monitoring, treatment or alleviation of disease,  diagnosis, monitoring, treatment, alleviation of or compensation for an injury or handicap,  investigation, replacement or modification of the anatomy or of a physiological process,
  • 8. control of conception which does not achieve its principal intended action in or on the human body by pharmacological, immunological or metabolic means, but which may be assisted in its function by such means; Dose the POPE know he should register the rythm method as a medical device
  • 9.
  • 10. DSCN 14/2009 Application of Patient Safety Risk Management to the Manufacture of Health Software
  • 11. ISB 0129  Health Informatics — Application of clinical risk management to the manufacture of health software (formerly ISO/TS 29321:2008(E))  DSCN14/2009  DSCN18/2009
  • 12. Safety Risk analysis  If the manufacturer can provide information showing that a safe design has been established for a number of years and that the product has been performing as intended during that time such information is likely to be sufficient to cover this requirement
  • 13. Modules Some stand alone software may break down into a significant number of applications for the user where each of these applications is correlated with a module. Some of these modules may have a medical purpose. This raises the issue as to whether the whole product can be CE marked when not all applications have a medical purpose It is the obligation of the manufacturer to identify the boundaries and the interfaces of the different modules/applications. SOS intended for use in combination with other modules of the whole software structure, other devices or equipment, the whole combination, including the connection system, must be safe and must not impair the specified performances of the modules which are subject to the medical device Directives.
  • 14. POST MARKET SURVEILLANCE  The Directive seeks to improve the protection of health and safety of patients, by reducing the likelihood of similar incidents being repeated. Consequently, the Regulations require the manufacturer to immediately notify the Competent Authority if the product has been involved in an incident:  Led to a death;  A serious injury or serious deterioration in the state of health  That might have led to death, serious injury
  • 15. DECLARATION OF CONFORMITY EC DECLARATION OF CONFORMITY (Full quality assurance system) The manufacturer must ensure application of the quality system approved for the design, manufacture and final inspection of the products concerned, as specified in Section 3 and is subject to audit as laid down in Sections 3.3 and 4 and to Community surveillance as specified in Section 5.
  • 16. What is a medical device  Any complex algorithm upon which a clinician may rely on where the calculation is not apparent to the clinician.  The software used for the Pandemic flu line has been classified as a medical device because it lead to patients receiving (or not) a medication.  CVS risk scope is almost certainly the same category.
  • 17. Decision Support Software Computer based tools which combines medical knowledge databases and algorithms with patient specific data. They are intended to provide healthcare professionals and/or users with recommendations for or information on diagnosis, prognosis, monitoring and treatment of individual patients.
  • 18. Active device for diagnosis: Any active medical device, whether used alone or in combination with other medical devices, to supply information for detecting, diagnosing, monitoring or treating physiological conditions, states of health, illnesses or congenital deformities.
  • 19. Drug dosing systems To calculate the drug dosage to be administered to a specific patient and therefore are qualified as medical devices. This would include drug doses filter by age sex gender indication.
  • 20. Expert function software: software which is able to analyse existing information to generate new specific information according to the intended use of the software.
  • 21. Intended purpose: the use for which the device is intended according to the data supplied by the manufacturer on the labelling, in the instructions and/or in promotional materials.
  • 22. Placing on the market: the first making available in return for payment or free of charge of a device other than a device intended for clinical investigation, with a view to distribution and/or use on the Community market, regardless of whether it is new or fully refurbished.
  • 23. Summary  If an APP influences a Clinician and probably also a Patient that results in subsequent therapy you should seriously consider if it is covered by the MDD and seek expert guidance  Clinical safety and quality management systems together with post marketing survelance are critical to the process.
  • 24. Questions  Neill.jones@nhs.net  MDD At MHRA  Full Directive
  • 25. www.handihealth.org info@handihealth.org Handi Health Community Interest Company - limited by guarantee registered in England number 07999302 Registered Office: The Oakley, Kidderminster Rd, Droitwich, Worcestershire. WR9 9AY Correspondence address: PO Box 5309 Leamington Spa, CV31 9GT